184 related articles for article (PubMed ID: 22015915)
1. Mammalian target of rapamycin (mTOR) activation in focal cortical dysplasia and related focal cortical malformations.
Wong M
Exp Neurol; 2013 Jun; 244():22-6. PubMed ID: 22015915
[TBL] [Abstract][Full Text] [Related]
2. Pilot study evaluating everolimus molecular mechanisms in tuberous sclerosis complex and focal cortical dysplasia.
Leitner DF; Kanshin E; Askenazi M; Siu Y; Friedman D; Devore S; Jones D; Ueberheide B; Wisniewski T; Devinsky O
PLoS One; 2022; 17(5):e0268597. PubMed ID: 35587487
[TBL] [Abstract][Full Text] [Related]
3. Somatic double-hit in MTOR and RPS6 in hemimegalencephaly with intractable epilepsy.
Pelorosso C; Watrin F; Conti V; Buhler E; Gelot A; Yang X; Mei D; McEvoy-Venneri J; Manent JB; Cetica V; Ball LL; Buccoliero AM; Vinck A; Barba C; Gleeson JG; Guerrini R; Represa A
Hum Mol Genet; 2019 Nov; 28(22):3755-3765. PubMed ID: 31411685
[TBL] [Abstract][Full Text] [Related]
4. Aberrant adenosine signaling in patients with focal cortical dysplasia.
Guo M; Zhang J; Wang J; Wang X; Gao Q; Tang C; Deng J; Xiong Z; Kong X; Guan Y; Zhou J; Boison D; Luan G; Li T
Mol Neurobiol; 2023 Aug; 60(8):4396-4417. PubMed ID: 37103687
[TBL] [Abstract][Full Text] [Related]
5. Targeting the EGFR pathway: An alternative strategy for the treatment of tuberous sclerosis complex?
Schachenhofer J; Gruber VE; Fehrer SV; Haider C; Glatter S; Liszewska E; Höftberger R; Aronica E; Rössler K; Jaworski J; Scholl T; Feucht M
Neuropathol Appl Neurobiol; 2024 Apr; 50(2):e12974. PubMed ID: 38562027
[TBL] [Abstract][Full Text] [Related]
6. Anti-seizure gene therapy for focal cortical dysplasia.
Almacellas Barbanoj A; Graham RT; Maffei B; Carpenter JC; Leite M; Hoke J; Hardjo F; Scott-Solache J; Chimonides C; Schorge S; Kullmann DM; Magloire V; Lignani G
Brain; 2024 Feb; 147(2):542-553. PubMed ID: 38100333
[TBL] [Abstract][Full Text] [Related]
7. Pathogenetic mechanisms of focal cortical dysplasia.
Marin-Valencia I; Guerrini R; Gleeson JG
Epilepsia; 2014 Jul; 55(7):970-8. PubMed ID: 24861491
[TBL] [Abstract][Full Text] [Related]
8. [Advances of pathological research and classification in malformations of cortical development associated with refractory epilepsy].
Fu YJ; Piao YS
Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):419-424. PubMed ID: 38678320
[TBL] [Abstract][Full Text] [Related]
9. Detection of somatic and germline pathogenic variants in adult cohort of drug-resistant focal epilepsies.
Ferri L; Menghi V; Licchetta L; Dimartino P; Minardi R; Davì C; Di Vito L; Cifaldi E; Zenesini C; Gozzo F; Pelliccia V; Mariani V; de Spelorzi YCC; Gustincich S; Seri M; Tassi L; Pippucci T; Bisulli F
Epilepsy Behav; 2024 Apr; 153():109716. PubMed ID: 38508103
[TBL] [Abstract][Full Text] [Related]
10. Somatic Mutations Activating the mTOR Pathway in Dorsal Telencephalic Progenitors Cause a Continuum of Cortical Dysplasias.
D'Gama AM; Woodworth MB; Hossain AA; Bizzotto S; Hatem NE; LaCoursiere CM; Najm I; Ying Z; Yang E; Barkovich AJ; Kwiatkowski DJ; Vinters HV; Madsen JR; Mathern GW; Blümcke I; Poduri A; Walsh CA
Cell Rep; 2017 Dec; 21(13):3754-3766. PubMed ID: 29281825
[TBL] [Abstract][Full Text] [Related]
11. Spatial omics reveals molecular changes in focal cortical dysplasia type II.
Vermeulen I; Rodriguez-Alvarez N; François L; Viot D; Poosti F; Aronica E; Dedeurwaerdere S; Barton P; Cillero-Pastor B; Heeren RMA
Neurobiol Dis; 2024 Jun; 195():106491. PubMed ID: 38575092
[TBL] [Abstract][Full Text] [Related]
12. Tuberous sclerosis complex: neurological, renal and pulmonary manifestations.
Franz DN; Bissler JJ; McCormack FX
Neuropediatrics; 2010 Oct; 41(5):199-208. PubMed ID: 21210335
[TBL] [Abstract][Full Text] [Related]
13. Genotype-phenotype correlations in focal malformations of cortical development: a pathway to integrated pathological diagnosis in epilepsy surgery.
Benova B; Jacques TS
Brain Pathol; 2019 Jul; 29(4):473-484. PubMed ID: 30485578
[TBL] [Abstract][Full Text] [Related]
14. NMDA receptor activation regulates sociability by its effect on mTOR signaling activity.
Burket JA; Benson AD; Tang AH; Deutsch SI
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jul; 60():60-5. PubMed ID: 25703582
[TBL] [Abstract][Full Text] [Related]
15. Targeted treatment trials for tuberous sclerosis and autism: no longer a dream.
Sahin M
Curr Opin Neurobiol; 2012 Oct; 22(5):895-901. PubMed ID: 22560338
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic MTOR somatic variant causing focal cortical dysplasia drives hyperexcitability via overactivation of neuronal GluN2C N-methyl-D-aspartate receptors.
Pineau L; Buhler E; Tarhini S; Bauer S; Crepel V; Watrin F; Cardoso C; Represa A; Szepetowski P; Burnashev N
Epilepsia; 2024 May; ():. PubMed ID: 38717560
[TBL] [Abstract][Full Text] [Related]
17. Targeting pathological cells with senolytic drugs reduces seizures in neurodevelopmental mTOR-related epilepsy.
Ribierre T; Bacq A; Donneger F; Doladilhe M; Maletic M; Roussel D; Le Roux I; Chassoux F; Devaux B; Adle-Biassette H; Ferrand-Sorbets S; Dorfmüller G; Chipaux M; Baldassari S; Poncer JC; Baulac S
Nat Neurosci; 2024 Jun; 27(6):1125-1136. PubMed ID: 38710875
[TBL] [Abstract][Full Text] [Related]
18. mTOR signaling in neural stem cells: from basic biology to disease.
Magri L; Galli R
Cell Mol Life Sci; 2013 Aug; 70(16):2887-98. PubMed ID: 23124271
[TBL] [Abstract][Full Text] [Related]
19. The zinc finger/RING domain protein Unkempt regulates cognitive flexibility.
Vinsland E; Baskaran P; Mihaylov SR; Hobbs C; Wood H; Bouybayoune I; Shah K; Houart C; Tee AR; Murn J; Fernandes C; Bateman JM
Sci Rep; 2021 Aug; 11(1):16299. PubMed ID: 34381067
[TBL] [Abstract][Full Text] [Related]
20. Ectopic HCN4 Provides a Target Biomarker for the Genetic Spectrum of mTORopathies.
Coleman M; Pinares-Garcia P; Stephenson SE; Lee WS; Kooshavar D; Mclean CA; Howell KB; Leventer RJ; Reid CA; Lockhart PJ
Neurol Genet; 2024 Apr; 10(2):e200135. PubMed ID: 38496361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
